Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 16, 2007

Waters Takes Over Calorimetry Sciences

  • Waters is acquiring Calorimetry Sciences (CSC), a manufacturer of high-performance calorimeters. Waters reports that the CSC business, with annual sales of approximately $4 million, will be added to its TA Instruments Division.

    "The technologies and products from CSC will complement our recently introduced TAM microcalorimeter product line and will further strengthen TA Instruments' industry-leading position in thermal analysis while increasing our exposure to the growing adoption of microcalorimetry in life science research and drug development," comments to Terry Kelly, president of TA Instruments.

    CSC’s key products are the Nano-ITC™, an isothermal titration calorimeter designed to measure protein-ligand binding, and the Nano-DSC™, an ultra-sensitive scanning calorimeter used for applications such as measuring the stability of proteins and other macromolecules in dilute solutions.

    Waters reports that the transaction is expected to be neutral to 2007 earnings. The company has a strong position in three complementary analytical technologies - liquid chromatography, mass spectrometry, and thermal analysis. These markets reportedly account for approximately $5 billion of the estimated $20- to $25-billion analytical instrumentation market.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »